The estimated Net Worth of John L Erb is at least $862 millier dollars as of 12 March 2019. Mr. Erb owns over 9,523 units of CHF Solutions Inc stock worth over $282,709 and over the last 7 years he sold CHFS stock worth over $0. In addition, he makes $579,758 as Chairman of the Board et Chief Executive Officer at CHF Solutions Inc.
John has made over 2 trades of the CHF Solutions Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 9,523 units of CHFS stock worth $49,996 on 12 March 2019.
The largest trade he's ever made was buying 23,584 units of CHF Solutions Inc stock on 3 July 2018 worth over $49,998. On average, John trades about 5,518 units every 42 days since 2017. As of 12 March 2019 he still owns at least 11,615 units of CHF Solutions Inc stock.
You can see the complete history of Mr. Erb stock trades at the bottom of the page.
John L. Erb is Chairman of the Board, Chief Executive Officer of the Company. He has served as chief executive officer and president of the Company since November 2015, as a director of the Company since September 2012 and as chairman of our Board since October 2012. Previously, Mr. Erb served as chief executive officer (from 2007 to 2020) of NuAx, Inc. (formerly Cardia Access, Inc.), a medical device company involved in developing new devices for the treatment of heart disease; he was executive chairman of the board (during 2007) and chief executive officer (from 2001 to 2006) of the previous owner of the Aquadex FlexFlow system, which was also known as CHF Solutions, Inc., a medical device company involved in the development, manufacturing and distribution of devices to treat congestive heart failure; as president and chief executive officer of IntraTherapeutics, Inc., a medical device company involved in the development, manufacturing and distribution of peripheral vascular stents, from 1997 to 2001; and in various positions, including as vice president of worldwide operations at Schneider, a division of Pfizer, Inc., from 1991 to 1997. Mr. Erb’s prior board experience includes service as a director of SenoRx, Inc., (a Nasdaq listed company), from December 2001 to July 2010; service as a director of CryoCath Technologies Inc., (a publicly traded Canadian company), from October 2000 to December 2008; and service as chairman of the board of Vascular Solutions, Inc., (a Nasdaq listed company), where he also served as chairman of the compensation and nominating and corporate governance committees. Mr. Erb currently serves as chairman of the board of Osprey Medical, Inc., (listed on the Australian Securities Exchange), where he also serves as a member of the compensation and audit committees, and as a director of Micromatrix. Mr. Erb also serves as a director and chief executive officer of NeuroMedic, Inc. since 2010 to the present.
As the Chairman of the Board et Chief Executive Officer of CHF Solutions Inc, the total compensation of John Erb at CHF Solutions Inc is $579,758. There are no executives at CHF Solutions Inc getting paid more.
John Erb is 71, he's been the Chairman of the Board et Chief Executive Officer of CHF Solutions Inc since 2020. There are no older and 8 younger executives at CHF Solutions Inc.
John's mailing address filed with the SEC is 12988 VALLEY VIEW ROAD, , EDEN PRAIRIE, MN, 55344.
Over the last 7 years, insiders at CHF Solutions Inc have traded over $74 worth of CHF Solutions Inc stock and bought 366,216 units worth $330,909 . The most active insiders traders include Ki Yong Choi, Gregory D Waller et John L Erb. On average, CHF Solutions Inc executives and independent directors trade stock every 97 days with the average trade being worth of $1,485,908. The most recent stock trade was executed by John L Erb on 12 March 2019, trading 9,523 units of CHFS stock currently worth $49,996.
CHF Solutions Inc executives and other stock owners filed with the SEC include: